nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—CYP2E1—Parkinson's disease	0.425	0.656	CbGaD
Flurazepam—ABCB1—Parkinson's disease	0.223	0.344	CbGaD
Flurazepam—GABRR3—peripheral nervous system—Parkinson's disease	0.00677	0.0459	CbGeAlD
Flurazepam—GABRR2—peripheral nervous system—Parkinson's disease	0.00587	0.0398	CbGeAlD
Flurazepam—GABRR1—peripheral nervous system—Parkinson's disease	0.00565	0.0383	CbGeAlD
Flurazepam—GABRR3—nerve—Parkinson's disease	0.00528	0.0357	CbGeAlD
Flurazepam—GABRQ—nerve—Parkinson's disease	0.00528	0.0357	CbGeAlD
Flurazepam—Quinacrine—PLA2G6—Parkinson's disease	0.00463	0.452	CrCbGaD
Flurazepam—GABRR2—nerve—Parkinson's disease	0.00458	0.031	CbGeAlD
Flurazepam—GABRR1—nerve—Parkinson's disease	0.00441	0.0298	CbGeAlD
Flurazepam—GABRA6—hindbrain—Parkinson's disease	0.00274	0.0186	CbGeAlD
Flurazepam—GABRQ—forebrain—Parkinson's disease	0.00219	0.0148	CbGeAlD
Flurazepam—GABRB2—hindbrain—Parkinson's disease	0.00202	0.0137	CbGeAlD
Flurazepam—GABRA2—hindbrain—Parkinson's disease	0.00185	0.0125	CbGeAlD
Flurazepam—GABRR1—forebrain—Parkinson's disease	0.00183	0.0124	CbGeAlD
Flurazepam—GABRA1—hindbrain—Parkinson's disease	0.00178	0.0121	CbGeAlD
Flurazepam—GABRD—forebrain—Parkinson's disease	0.00159	0.0107	CbGeAlD
Flurazepam—GABRA6—brainstem—Parkinson's disease	0.00157	0.0107	CbGeAlD
Flurazepam—GABRG1—forebrain—Parkinson's disease	0.00153	0.0103	CbGeAlD
Flurazepam—GABRA5—forebrain—Parkinson's disease	0.00147	0.00997	CbGeAlD
Flurazepam—GABRA4—forebrain—Parkinson's disease	0.00134	0.00905	CbGeAlD
Flurazepam—GABRR3—head—Parkinson's disease	0.00125	0.00848	CbGeAlD
Flurazepam—GABRQ—head—Parkinson's disease	0.00125	0.00848	CbGeAlD
Flurazepam—GABRR3—nervous system—Parkinson's disease	0.00119	0.00804	CbGeAlD
Flurazepam—GABRQ—nervous system—Parkinson's disease	0.00119	0.00804	CbGeAlD
Flurazepam—GABRB2—brainstem—Parkinson's disease	0.00116	0.00784	CbGeAlD
Flurazepam—GABRD—medulla oblongata—Parkinson's disease	0.00115	0.00776	CbGeAlD
Flurazepam—GABRQ—central nervous system—Parkinson's disease	0.00114	0.00774	CbGeAlD
Flurazepam—GABRB2—forebrain—Parkinson's disease	0.00112	0.00757	CbGeAlD
Flurazepam—GABRG2—forebrain—Parkinson's disease	0.00112	0.00757	CbGeAlD
Flurazepam—GABRG1—medulla oblongata—Parkinson's disease	0.0011	0.00747	CbGeAlD
Flurazepam—GABRG3—head—Parkinson's disease	0.0011	0.00743	CbGeAlD
Flurazepam—GABRR2—head—Parkinson's disease	0.00109	0.00735	CbGeAlD
Flurazepam—GABRB1—medulla oblongata—Parkinson's disease	0.00107	0.00724	CbGeAlD
Flurazepam—GABRA2—brainstem—Parkinson's disease	0.00106	0.00716	CbGeAlD
Flurazepam—GABRD—midbrain—Parkinson's disease	0.00105	0.00709	CbGeAlD
Flurazepam—GABRR1—head—Parkinson's disease	0.00105	0.00708	CbGeAlD
Flurazepam—GABRG3—nervous system—Parkinson's disease	0.00104	0.00704	CbGeAlD
Flurazepam—GABRR2—nervous system—Parkinson's disease	0.00103	0.00697	CbGeAlD
Flurazepam—GABRA1—brainstem—Parkinson's disease	0.00102	0.00692	CbGeAlD
Flurazepam—GABRA2—forebrain—Parkinson's disease	0.00102	0.00691	CbGeAlD
Flurazepam—GABRG1—midbrain—Parkinson's disease	0.00101	0.00683	CbGeAlD
Flurazepam—GABRG3—central nervous system—Parkinson's disease	0.001	0.00678	CbGeAlD
Flurazepam—GABRR1—nervous system—Parkinson's disease	0.000991	0.00671	CbGeAlD
Flurazepam—GABRA1—forebrain—Parkinson's disease	0.000987	0.00668	CbGeAlD
Flurazepam—GABRG1—spinal cord—Parkinson's disease	0.000984	0.00666	CbGeAlD
Flurazepam—GABRB1—midbrain—Parkinson's disease	0.000978	0.00662	CbGeAlD
Flurazepam—GABRR2—cerebellum—Parkinson's disease	0.000969	0.00656	CbGeAlD
Flurazepam—GABRR1—central nervous system—Parkinson's disease	0.000954	0.00646	CbGeAlD
Flurazepam—GABRB1—spinal cord—Parkinson's disease	0.000954	0.00646	CbGeAlD
Flurazepam—GABRD—head—Parkinson's disease	0.000908	0.00615	CbGeAlD
Flurazepam—GABRQ—brain—Parkinson's disease	0.000908	0.00615	CbGeAlD
Flurazepam—GABRG1—head—Parkinson's disease	0.000874	0.00592	CbGeAlD
Flurazepam—GABRA6—head—Parkinson's disease	0.000869	0.00589	CbGeAlD
Flurazepam—GABRD—nervous system—Parkinson's disease	0.000861	0.00583	CbGeAlD
Flurazepam—GABRB3—forebrain—Parkinson's disease	0.000858	0.00581	CbGeAlD
Flurazepam—GABRB1—head—Parkinson's disease	0.000848	0.00574	CbGeAlD
Flurazepam—GABRA5—head—Parkinson's disease	0.000843	0.00571	CbGeAlD
Flurazepam—GABRD—central nervous system—Parkinson's disease	0.000829	0.00561	CbGeAlD
Flurazepam—GABRG1—nervous system—Parkinson's disease	0.000829	0.00561	CbGeAlD
Flurazepam—GABRA6—nervous system—Parkinson's disease	0.000824	0.00558	CbGeAlD
Flurazepam—GABRD—cerebellum—Parkinson's disease	0.00081	0.00549	CbGeAlD
Flurazepam—GABRB2—medulla oblongata—Parkinson's disease	0.000807	0.00547	CbGeAlD
Flurazepam—GABRG2—medulla oblongata—Parkinson's disease	0.000807	0.00547	CbGeAlD
Flurazepam—GABRB1—nervous system—Parkinson's disease	0.000804	0.00544	CbGeAlD
Flurazepam—GABRA5—nervous system—Parkinson's disease	0.000799	0.00541	CbGeAlD
Flurazepam—GABRG1—central nervous system—Parkinson's disease	0.000798	0.0054	CbGeAlD
Flurazepam—GABRG3—brain—Parkinson's disease	0.000795	0.00538	CbGeAlD
Flurazepam—GABRA6—central nervous system—Parkinson's disease	0.000793	0.00537	CbGeAlD
Flurazepam—GABRA3—head—Parkinson's disease	0.000785	0.00532	CbGeAlD
Flurazepam—GABRG1—cerebellum—Parkinson's disease	0.00078	0.00528	CbGeAlD
Flurazepam—GABRA6—cerebellum—Parkinson's disease	0.000776	0.00525	CbGeAlD
Flurazepam—GABRB1—central nervous system—Parkinson's disease	0.000774	0.00524	CbGeAlD
Flurazepam—GABRA5—central nervous system—Parkinson's disease	0.00077	0.00521	CbGeAlD
Flurazepam—GABRA4—head—Parkinson's disease	0.000765	0.00518	CbGeAlD
Flurazepam—GABRP—head—Parkinson's disease	0.000759	0.00514	CbGeAlD
Flurazepam—GABRR1—brain—Parkinson's disease	0.000757	0.00513	CbGeAlD
Flurazepam—GABRB1—cerebellum—Parkinson's disease	0.000756	0.00512	CbGeAlD
Flurazepam—GABRA3—nervous system—Parkinson's disease	0.000744	0.00504	CbGeAlD
Flurazepam—GABRB2—midbrain—Parkinson's disease	0.000738	0.005	CbGeAlD
Flurazepam—GABRG2—midbrain—Parkinson's disease	0.000738	0.005	CbGeAlD
Flurazepam—GABRA4—nervous system—Parkinson's disease	0.000725	0.00491	CbGeAlD
Flurazepam—GABRB2—spinal cord—Parkinson's disease	0.00072	0.00488	CbGeAlD
Flurazepam—GABRG2—spinal cord—Parkinson's disease	0.00072	0.00488	CbGeAlD
Flurazepam—GABRA3—central nervous system—Parkinson's disease	0.000717	0.00485	CbGeAlD
Flurazepam—GABRA1—medulla oblongata—Parkinson's disease	0.000713	0.00483	CbGeAlD
Flurazepam—GABRA4—central nervous system—Parkinson's disease	0.000698	0.00473	CbGeAlD
Flurazepam—GABRA4—cerebellum—Parkinson's disease	0.000683	0.00462	CbGeAlD
Flurazepam—GABRD—brain—Parkinson's disease	0.000658	0.00446	CbGeAlD
Flurazepam—GABRA1—midbrain—Parkinson's disease	0.000652	0.00441	CbGeAlD
Flurazepam—GABRB2—head—Parkinson's disease	0.00064	0.00433	CbGeAlD
Flurazepam—GABRG2—head—Parkinson's disease	0.00064	0.00433	CbGeAlD
Flurazepam—GABRA1—spinal cord—Parkinson's disease	0.000636	0.00431	CbGeAlD
Flurazepam—GABRG1—brain—Parkinson's disease	0.000634	0.00429	CbGeAlD
Flurazepam—GABRA6—brain—Parkinson's disease	0.00063	0.00427	CbGeAlD
Flurazepam—GABRB3—medulla oblongata—Parkinson's disease	0.00062	0.0042	CbGeAlD
Flurazepam—GABRB1—brain—Parkinson's disease	0.000614	0.00416	CbGeAlD
Flurazepam—GABRA5—brain—Parkinson's disease	0.000611	0.00414	CbGeAlD
Flurazepam—GABRB2—nervous system—Parkinson's disease	0.000607	0.00411	CbGeAlD
Flurazepam—GABRG2—nervous system—Parkinson's disease	0.000607	0.00411	CbGeAlD
Flurazepam—CYP2A6—cerebellum—Parkinson's disease	0.00059	0.004	CbGeAlD
Flurazepam—GABRA2—head—Parkinson's disease	0.000585	0.00396	CbGeAlD
Flurazepam—GABRB2—central nervous system—Parkinson's disease	0.000584	0.00396	CbGeAlD
Flurazepam—GABRG2—central nervous system—Parkinson's disease	0.000584	0.00396	CbGeAlD
Flurazepam—GABRE—head—Parkinson's disease	0.00058	0.00393	CbGeAlD
Flurazepam—GABRB2—cerebellum—Parkinson's disease	0.000571	0.00387	CbGeAlD
Flurazepam—GABRG2—cerebellum—Parkinson's disease	0.000571	0.00387	CbGeAlD
Flurazepam—GABRA3—brain—Parkinson's disease	0.000569	0.00385	CbGeAlD
Flurazepam—Chloroquine—TNF—Parkinson's disease	0.000567	0.0554	CrCbGaD
Flurazepam—GABRB3—midbrain—Parkinson's disease	0.000567	0.00384	CbGeAlD
Flurazepam—GABRA1—head—Parkinson's disease	0.000565	0.00383	CbGeAlD
Flurazepam—GABRA4—brain—Parkinson's disease	0.000554	0.00375	CbGeAlD
Flurazepam—GABRA2—nervous system—Parkinson's disease	0.000554	0.00375	CbGeAlD
Flurazepam—GABRB3—spinal cord—Parkinson's disease	0.000553	0.00374	CbGeAlD
Flurazepam—GABRE—nervous system—Parkinson's disease	0.00055	0.00372	CbGeAlD
Flurazepam—GABRA1—nervous system—Parkinson's disease	0.000536	0.00363	CbGeAlD
Flurazepam—GABRA2—central nervous system—Parkinson's disease	0.000534	0.00361	CbGeAlD
Flurazepam—GABRE—central nervous system—Parkinson's disease	0.000529	0.00358	CbGeAlD
Flurazepam—GABRA2—cerebellum—Parkinson's disease	0.000522	0.00353	CbGeAlD
Flurazepam—GABRA1—central nervous system—Parkinson's disease	0.000516	0.00349	CbGeAlD
Flurazepam—GABRA1—cerebellum—Parkinson's disease	0.000504	0.00341	CbGeAlD
Flurazepam—GABRB3—head—Parkinson's disease	0.000491	0.00333	CbGeAlD
Flurazepam—CYP2A6—brain—Parkinson's disease	0.000479	0.00325	CbGeAlD
Flurazepam—GABRB3—nervous system—Parkinson's disease	0.000466	0.00315	CbGeAlD
Flurazepam—GABRG2—brain—Parkinson's disease	0.000464	0.00314	CbGeAlD
Flurazepam—GABRB2—brain—Parkinson's disease	0.000464	0.00314	CbGeAlD
Flurazepam—CYP2E1—cardiovascular system—Parkinson's disease	0.000462	0.00313	CbGeAlD
Flurazepam—GABRB3—central nervous system—Parkinson's disease	0.000449	0.00304	CbGeAlD
Flurazepam—Amodiaquine—CYP2D6—Parkinson's disease	0.000444	0.0433	CrCbGaD
Flurazepam—GABRB3—cerebellum—Parkinson's disease	0.000438	0.00297	CbGeAlD
Flurazepam—GABRA2—brain—Parkinson's disease	0.000424	0.00287	CbGeAlD
Flurazepam—GABRE—brain—Parkinson's disease	0.00042	0.00284	CbGeAlD
Flurazepam—GABRA1—brain—Parkinson's disease	0.000409	0.00277	CbGeAlD
Flurazepam—CYP2E1—medulla oblongata—Parkinson's disease	0.000395	0.00267	CbGeAlD
Flurazepam—GABRB3—brain—Parkinson's disease	0.000356	0.00241	CbGeAlD
Flurazepam—CYP2E1—spinal cord—Parkinson's disease	0.000352	0.00238	CbGeAlD
Flurazepam—ABCB1—embryo—Parkinson's disease	0.000352	0.00238	CbGeAlD
Flurazepam—Clomipramine—GSTP1—Parkinson's disease	0.000339	0.0331	CrCbGaD
Flurazepam—Chloroquine—CYP2D6—Parkinson's disease	0.000321	0.0313	CrCbGaD
Flurazepam—CYP2E1—head—Parkinson's disease	0.000313	0.00212	CbGeAlD
Flurazepam—ABCB1—forebrain—Parkinson's disease	0.000311	0.00211	CbGeAlD
Flurazepam—CYP2E1—nervous system—Parkinson's disease	0.000296	0.00201	CbGeAlD
Flurazepam—CYP2E1—central nervous system—Parkinson's disease	0.000285	0.00193	CbGeAlD
Flurazepam—CYP2E1—cerebellum—Parkinson's disease	0.000279	0.00189	CbGeAlD
Flurazepam—ABCB1—cardiovascular system—Parkinson's disease	0.000263	0.00178	CbGeAlD
Flurazepam—Chlorprothixene—DRD3—Parkinson's disease	0.00026	0.0254	CrCbGaD
Flurazepam—Quinacrine—ABCB1—Parkinson's disease	0.000258	0.0252	CrCbGaD
Flurazepam—Chlorprothixene—DRD1—Parkinson's disease	0.000255	0.0249	CrCbGaD
Flurazepam—Clonazepam—CYP2E1—Parkinson's disease	0.000251	0.0245	CrCbGaD
Flurazepam—CYP3A4—nervous system—Parkinson's disease	0.000239	0.00162	CbGeAlD
Flurazepam—CYP3A4—central nervous system—Parkinson's disease	0.00023	0.00155	CbGeAlD
Flurazepam—Chloroquine—ABCB1—Parkinson's disease	0.000229	0.0224	CrCbGaD
Flurazepam—CYP2E1—brain—Parkinson's disease	0.000227	0.00153	CbGeAlD
Flurazepam—ABCB1—medulla oblongata—Parkinson's disease	0.000225	0.00152	CbGeAlD
Flurazepam—ABCB1—midbrain—Parkinson's disease	0.000205	0.00139	CbGeAlD
Flurazepam—Flunitrazepam—CYP2E1—Parkinson's disease	0.000202	0.0197	CrCbGaD
Flurazepam—ABCB1—spinal cord—Parkinson's disease	0.0002	0.00136	CbGeAlD
Flurazepam—Chlorpromazine—HTR7—Parkinson's disease	0.000191	0.0186	CrCbGaD
Flurazepam—Chlorprothixene—DRD2—Parkinson's disease	0.00018	0.0176	CrCbGaD
Flurazepam—Chlorpromazine—DRD3—Parkinson's disease	0.000179	0.0175	CrCbGaD
Flurazepam—ABCB1—head—Parkinson's disease	0.000178	0.00121	CbGeAlD
Flurazepam—Chlorpromazine—DRD1—Parkinson's disease	0.000176	0.0172	CrCbGaD
Flurazepam—ABCB1—nervous system—Parkinson's disease	0.000169	0.00114	CbGeAlD
Flurazepam—ABCB1—central nervous system—Parkinson's disease	0.000163	0.0011	CbGeAlD
Flurazepam—ABCB1—cerebellum—Parkinson's disease	0.000159	0.00108	CbGeAlD
Flurazepam—Midazolam—CYP2E1—Parkinson's disease	0.00015	0.0146	CrCbGaD
Flurazepam—Chlorpromazine—HTR1A—Parkinson's disease	0.000146	0.0143	CrCbGaD
Flurazepam—Clomipramine—HTR2A—Parkinson's disease	0.00014	0.0136	CrCbGaD
Flurazepam—Chlorprothixene—HTR2A—Parkinson's disease	0.000139	0.0136	CrCbGaD
Flurazepam—ABCB1—brain—Parkinson's disease	0.000129	0.000874	CbGeAlD
Flurazepam—Diazepam—CYP2E1—Parkinson's disease	0.000129	0.0125	CrCbGaD
Flurazepam—Clomipramine—CYP2D6—Parkinson's disease	0.000128	0.0125	CrCbGaD
Flurazepam—Chlorpromazine—DRD2—Parkinson's disease	0.000124	0.0121	CrCbGaD
Flurazepam—Chlorpromazine—CYP2E1—Parkinson's disease	0.000119	0.0117	CrCbGaD
Flurazepam—Clobazam—ABCB1—Parkinson's disease	0.000115	0.0113	CrCbGaD
Flurazepam—Chlorpromazine—HTR2A—Parkinson's disease	9.58e-05	0.00935	CrCbGaD
Flurazepam—Clomipramine—ABCB1—Parkinson's disease	9.12e-05	0.00891	CrCbGaD
Flurazepam—Chlorprothixene—ABCB1—Parkinson's disease	9.08e-05	0.00887	CrCbGaD
Flurazepam—Chlorpromazine—CYP2D6—Parkinson's disease	8.76e-05	0.00855	CrCbGaD
Flurazepam—Midazolam—ABCB1—Parkinson's disease	7.86e-05	0.00768	CrCbGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	6.93e-05	0.000358	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	6.83e-05	0.000353	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.82e-05	0.000352	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	6.78e-05	0.00035	CbGpPWpGaD
Flurazepam—Diazepam—ABCB1—Parkinson's disease	6.74e-05	0.00658	CrCbGaD
Flurazepam—CYP2E1—Biological oxidations—COMT—Parkinson's disease	6.7e-05	0.000346	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	6.67e-05	0.000344	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	6.65e-05	0.000343	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	6.61e-05	0.000341	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.59e-05	0.00034	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	6.58e-05	0.000339	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.55e-05	0.000338	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.51e-05	0.000336	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.51e-05	0.000336	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	6.47e-05	0.000334	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.42e-05	0.000331	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.32e-05	0.000326	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—COMT—Parkinson's disease	6.27e-05	0.000324	CbGpPWpGaD
Flurazepam—Chlorpromazine—ABCB1—Parkinson's disease	6.26e-05	0.00611	CrCbGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.24e-05	0.000322	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.24e-05	0.000322	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MAOA—Parkinson's disease	6.23e-05	0.000321	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	6.23e-05	0.000321	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	6.23e-05	0.000321	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	6.19e-05	0.00032	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.16e-05	0.000318	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	6.13e-05	0.000316	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	6.11e-05	0.000315	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.07e-05	0.000313	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	6.06e-05	0.000313	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.05e-05	0.000312	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	6.04e-05	0.000312	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MCCC1—Parkinson's disease	5.99e-05	0.000309	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ND3—Parkinson's disease	5.99e-05	0.000309	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.98e-05	0.000309	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	5.94e-05	0.000307	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.91e-05	0.000305	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.81e-05	0.0003	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.74e-05	0.000296	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.67e-05	0.000293	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—OMD—Parkinson's disease	5.63e-05	0.000291	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TALDO1—Parkinson's disease	5.63e-05	0.000291	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.57e-05	0.000287	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	5.52e-05	0.000285	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ND3—Parkinson's disease	5.5e-05	0.000284	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MCCC1—Parkinson's disease	5.5e-05	0.000284	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.4e-05	0.000279	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.36e-05	0.000276	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	5.34e-05	0.000275	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.28e-05	0.000272	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.25e-05	0.000271	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.22e-05	0.000269	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.21e-05	0.000269	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.19e-05	0.000268	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TALDO1—Parkinson's disease	5.17e-05	0.000267	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—OMD—Parkinson's disease	5.17e-05	0.000267	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.15e-05	0.000266	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.14e-05	0.000265	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GCH1—Parkinson's disease	5.09e-05	0.000263	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.07e-05	0.000261	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.06e-05	0.000261	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.04e-05	0.00026	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.03e-05	0.00026	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.99e-05	0.000258	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.95e-05	0.000255	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.94e-05	0.000255	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.93e-05	0.000254	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NDUFB11—Parkinson's disease	4.9e-05	0.000253	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.86e-05	0.000251	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.83e-05	0.000249	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.79e-05	0.000247	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.74e-05	0.000245	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.73e-05	0.000244	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GCH1—Parkinson's disease	4.67e-05	0.000241	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—DBH—Parkinson's disease	4.54e-05	0.000234	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GBA—Parkinson's disease	4.54e-05	0.000234	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—FBP1—Parkinson's disease	4.54e-05	0.000234	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	4.51e-05	0.000233	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	4.51e-05	0.000233	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.51e-05	0.000233	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	4.5e-05	0.000232	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	4.44e-05	0.000229	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.38e-05	0.000226	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ND3—Parkinson's disease	4.34e-05	0.000224	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MCCC1—Parkinson's disease	4.34e-05	0.000224	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.33e-05	0.000223	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.32e-05	0.000223	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.3e-05	0.000222	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.23e-05	0.000218	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.2e-05	0.000217	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.2e-05	0.000217	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GBA—Parkinson's disease	4.17e-05	0.000215	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—DBH—Parkinson's disease	4.17e-05	0.000215	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—FBP1—Parkinson's disease	4.17e-05	0.000215	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.15e-05	0.000214	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.13e-05	0.000213	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.12e-05	0.000213	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	4.1e-05	0.000212	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TALDO1—Parkinson's disease	4.08e-05	0.000211	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—OMD—Parkinson's disease	4.08e-05	0.000211	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.06e-05	0.000209	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.04e-05	0.000209	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.03e-05	0.000208	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.97e-05	0.000205	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.96e-05	0.000204	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	3.94e-05	0.000204	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	3.87e-05	0.0002	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.81e-05	0.000196	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.79e-05	0.000195	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	3.75e-05	0.000194	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.7e-05	0.000191	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GCH1—Parkinson's disease	3.69e-05	0.000191	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.6e-05	0.000186	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.46e-05	0.000179	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—DDC—Parkinson's disease	3.33e-05	0.000172	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.31e-05	0.000171	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.3e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GBA—Parkinson's disease	3.29e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FBP1—Parkinson's disease	3.29e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—DBH—Parkinson's disease	3.29e-05	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—Parkinson's disease	3.27e-05	0.000169	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ND3—Parkinson's disease	3.27e-05	0.000169	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MCCC1—Parkinson's disease	3.27e-05	0.000169	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.18e-05	0.000164	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTA4—Parkinson's disease	3.15e-05	0.000162	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.11e-05	0.00016	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.09e-05	0.00016	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.09e-05	0.000159	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TALDO1—Parkinson's disease	3.08e-05	0.000159	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—OMD—Parkinson's disease	3.08e-05	0.000159	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.07e-05	0.000158	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—DDC—Parkinson's disease	3.06e-05	0.000158	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.05e-05	0.000158	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.05e-05	0.000157	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.04e-05	0.000157	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NDUFB11—Parkinson's disease	2.92e-05	0.00015	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTA4—Parkinson's disease	2.89e-05	0.000149	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.84e-05	0.000147	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	2.83e-05	0.000146	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MAOB—Parkinson's disease	2.8e-05	0.000145	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.8e-05	0.000145	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GCH1—Parkinson's disease	2.78e-05	0.000144	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	2.6e-05	0.000134	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MAOB—Parkinson's disease	2.57e-05	0.000133	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FBP1—Parkinson's disease	2.48e-05	0.000128	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GBA—Parkinson's disease	2.48e-05	0.000128	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—DBH—Parkinson's disease	2.48e-05	0.000128	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—DDC—Parkinson's disease	2.42e-05	0.000125	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.28e-05	0.000118	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.22e-05	0.000115	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.17e-05	0.000112	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	2.08e-05	0.000108	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.08e-05	0.000107	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.05e-05	0.000106	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CTGF—Parkinson's disease	2.05e-05	0.000106	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.04e-05	0.000105	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.03e-05	0.000105	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ND3—Parkinson's disease	2.02e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.02e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	1.91e-05	9.87e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	1.91e-05	9.84e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—OMD—Parkinson's disease	1.9e-05	9.78e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.9e-05	9.78e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NQO1—Parkinson's disease	1.88e-05	9.73e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CTGF—Parkinson's disease	1.88e-05	9.69e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TH—Parkinson's disease	1.86e-05	9.59e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—DDC—Parkinson's disease	1.82e-05	9.39e-05	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.81e-05	9.33e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.8e-05	9.27e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYCS—Parkinson's disease	1.78e-05	9.2e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	9.03e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NQO1—Parkinson's disease	1.73e-05	8.93e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.72e-05	8.87e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.71e-05	8.84e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TH—Parkinson's disease	1.71e-05	8.8e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYCS—Parkinson's disease	1.64e-05	8.45e-05	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.61e-05	8.33e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—COMT—Parkinson's disease	1.58e-05	8.15e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—Parkinson's disease	1.57e-05	8.11e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MAOA—Parkinson's disease	1.57e-05	8.09e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—HMOX1—Parkinson's disease	1.55e-05	8e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.55e-05	7.99e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MAOB—Parkinson's disease	1.53e-05	7.91e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—DBH—Parkinson's disease	1.53e-05	7.88e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.53e-05	7.88e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GBA—Parkinson's disease	1.53e-05	7.88e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.51e-05	7.8e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ABCB1—Parkinson's disease	1.49e-05	7.68e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.48e-05	7.66e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—COMT—Parkinson's disease	1.45e-05	7.48e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTM1—Parkinson's disease	1.44e-05	7.45e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.44e-05	7.45e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.44e-05	7.43e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.42e-05	7.34e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPX1—Parkinson's disease	1.38e-05	7.14e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.37e-05	7.06e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.37e-05	7.05e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TH—Parkinson's disease	1.35e-05	6.95e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.33e-05	6.84e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.29e-05	6.68e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MTHFR—Parkinson's disease	1.28e-05	6.59e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPX1—Parkinson's disease	1.27e-05	6.55e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOE—Parkinson's disease	1.19e-05	6.13e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MTHFR—Parkinson's disease	1.17e-05	6.05e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—COMT—Parkinson's disease	1.15e-05	5.91e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.14e-05	5.88e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.14e-05	5.88e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.14e-05	5.87e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.12e-05	5.8e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—DDC—Parkinson's disease	1.12e-05	5.79e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CTGF—Parkinson's disease	1.12e-05	5.77e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOE—Parkinson's disease	1.09e-05	5.63e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.08e-05	5.57e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.06e-05	5.46e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.05e-05	5.41e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.04e-05	5.37e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NQO1—Parkinson's disease	1.03e-05	5.31e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—INS—Parkinson's disease	1.02e-05	5.24e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TH—Parkinson's disease	1.01e-05	5.24e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPX1—Parkinson's disease	1e-05	5.18e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYCS—Parkinson's disease	9.74e-06	5.03e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.53e-06	4.92e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.44e-06	4.87e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—INS—Parkinson's disease	9.32e-06	4.81e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MTHFR—Parkinson's disease	9.26e-06	4.78e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—COMT—Parkinson's disease	8.63e-06	4.45e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOE—Parkinson's disease	8.62e-06	4.45e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—Parkinson's disease	8.59e-06	4.43e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MAOA—Parkinson's disease	8.57e-06	4.42e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—HMOX1—Parkinson's disease	8.47e-06	4.37e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTM1—Parkinson's disease	7.89e-06	4.07e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPX1—Parkinson's disease	7.56e-06	3.9e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—INS—Parkinson's disease	7.37e-06	3.8e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	7.01e-06	3.62e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MTHFR—Parkinson's disease	6.97e-06	3.6e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.88e-06	3.55e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOE—Parkinson's disease	6.49e-06	3.35e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.41e-06	3.31e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.34e-06	3.27e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TH—Parkinson's disease	6.25e-06	3.23e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYCS—Parkinson's disease	6e-06	3.1e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—INS—Parkinson's disease	5.55e-06	2.86e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—COMT—Parkinson's disease	5.32e-06	2.74e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.29e-06	2.73e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.28e-06	2.72e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.22e-06	2.69e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.01e-06	2.58e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.86e-06	2.51e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.66e-06	2.4e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.3e-06	2.22e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOE—Parkinson's disease	4e-06	2.06e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—INS—Parkinson's disease	3.42e-06	1.76e-05	CbGpPWpGaD
